Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey
The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to...
Saved in:
Published in | Anticancer research Vol. 34; no. 8; p. 4439 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Greece
01.08.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1791-7530 1791-7530 |
Cover
Abstract | The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to analyze the thyroid cancer detection rate in asymptomatic individuals through a FDG-PET cancer screening program in Japan.
A total of 153,775 asymptomatic individuals underwent FDG-PET cancer screening. We analyzed 1,308 cases for possible thyroid cancer in all screening tests.
Among the 1,308 possible cases, 353 were verified as thyroid cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET were 90.7% and 29.5% for thyroid cancer, respectively. The relative sensitivity was equivalent to thyroid ultrasonography (US) (90.9%) and higher than neck computed tomography (CT) (75.7%, p<0.001), thyroglobulin (36.1%, p<0.001), and carcinoembryonic antigen (5.6%, p<0.001). The sensitivity with a PET/CT scanner was higher than that with a dedicated PET scanner (94.1% vs. 85.0%, p<0.001). Combining thyroid US with FDG-PET increased the relative sensitivity and PPV. The majority of thyroid carcinomas detected by FDG-PET screening were Union for International Cancer Control (UICC) stage I, but a significant number of cases were also detected as stage III or IV.
The FDG-PET cancer screening program in Japan detected thyroid cancer at an early stage. FDG-PET showed high sensitivity in detecting thyroid cancer, and it may be more effective if combined with thyroid US. |
---|---|
AbstractList | The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to analyze the thyroid cancer detection rate in asymptomatic individuals through a FDG-PET cancer screening program in Japan.
A total of 153,775 asymptomatic individuals underwent FDG-PET cancer screening. We analyzed 1,308 cases for possible thyroid cancer in all screening tests.
Among the 1,308 possible cases, 353 were verified as thyroid cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET were 90.7% and 29.5% for thyroid cancer, respectively. The relative sensitivity was equivalent to thyroid ultrasonography (US) (90.9%) and higher than neck computed tomography (CT) (75.7%, p<0.001), thyroglobulin (36.1%, p<0.001), and carcinoembryonic antigen (5.6%, p<0.001). The sensitivity with a PET/CT scanner was higher than that with a dedicated PET scanner (94.1% vs. 85.0%, p<0.001). Combining thyroid US with FDG-PET increased the relative sensitivity and PPV. The majority of thyroid carcinomas detected by FDG-PET screening were Union for International Cancer Control (UICC) stage I, but a significant number of cases were also detected as stage III or IV.
The FDG-PET cancer screening program in Japan detected thyroid cancer at an early stage. FDG-PET showed high sensitivity in detecting thyroid cancer, and it may be more effective if combined with thyroid US. The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to analyze the thyroid cancer detection rate in asymptomatic individuals through a FDG-PET cancer screening program in Japan.BACKGROUND/AIMThe [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to analyze the thyroid cancer detection rate in asymptomatic individuals through a FDG-PET cancer screening program in Japan.A total of 153,775 asymptomatic individuals underwent FDG-PET cancer screening. We analyzed 1,308 cases for possible thyroid cancer in all screening tests.MATERIALS AND METHODSA total of 153,775 asymptomatic individuals underwent FDG-PET cancer screening. We analyzed 1,308 cases for possible thyroid cancer in all screening tests.Among the 1,308 possible cases, 353 were verified as thyroid cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET were 90.7% and 29.5% for thyroid cancer, respectively. The relative sensitivity was equivalent to thyroid ultrasonography (US) (90.9%) and higher than neck computed tomography (CT) (75.7%, p<0.001), thyroglobulin (36.1%, p<0.001), and carcinoembryonic antigen (5.6%, p<0.001). The sensitivity with a PET/CT scanner was higher than that with a dedicated PET scanner (94.1% vs. 85.0%, p<0.001). Combining thyroid US with FDG-PET increased the relative sensitivity and PPV. The majority of thyroid carcinomas detected by FDG-PET screening were Union for International Cancer Control (UICC) stage I, but a significant number of cases were also detected as stage III or IV.RESULTSAmong the 1,308 possible cases, 353 were verified as thyroid cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET were 90.7% and 29.5% for thyroid cancer, respectively. The relative sensitivity was equivalent to thyroid ultrasonography (US) (90.9%) and higher than neck computed tomography (CT) (75.7%, p<0.001), thyroglobulin (36.1%, p<0.001), and carcinoembryonic antigen (5.6%, p<0.001). The sensitivity with a PET/CT scanner was higher than that with a dedicated PET scanner (94.1% vs. 85.0%, p<0.001). Combining thyroid US with FDG-PET increased the relative sensitivity and PPV. The majority of thyroid carcinomas detected by FDG-PET screening were Union for International Cancer Control (UICC) stage I, but a significant number of cases were also detected as stage III or IV.The FDG-PET cancer screening program in Japan detected thyroid cancer at an early stage. FDG-PET showed high sensitivity in detecting thyroid cancer, and it may be more effective if combined with thyroid US.CONCLUSIONThe FDG-PET cancer screening program in Japan detected thyroid cancer at an early stage. FDG-PET showed high sensitivity in detecting thyroid cancer, and it may be more effective if combined with thyroid US. |
Author | Jinnouchi, Seishi Inoue, Tomio Yoshida, Tsuyoshi Minamimoto, Ryogo Senda, Michio Terauchi, Takashi |
Author_xml | – sequence: 1 givenname: Ryogo surname: Minamimoto fullname: Minamimoto, Ryogo email: ryogominamimoto@yahoo.co.jp organization: Division of Nuclear Medicine, Department of Radiology, National Center for Global Health, Tokyo, Japan Department of Radiology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ryogominamimoto@yahoo.co.jp – sequence: 2 givenname: Michio surname: Senda fullname: Senda, Michio organization: Division of Molecular Imaging, Institute of Biomedical Research and Innovation, Kobe, Japan – sequence: 3 givenname: Seishi surname: Jinnouchi fullname: Jinnouchi, Seishi organization: Atsuchi Memorial Institute of Radiology, Atsuchi Memorial Clinic PET Center, Kagoshima, Japan – sequence: 4 givenname: Takashi surname: Terauchi fullname: Terauchi, Takashi organization: Division of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan – sequence: 5 givenname: Tsuyoshi surname: Yoshida fullname: Yoshida, Tsuyoshi organization: Department of Radiology, Koga Hospital 21 PET Center, Kurume, Japan – sequence: 6 givenname: Tomio surname: Inoue fullname: Inoue, Tomio organization: Department of Radiology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25075083$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkE1LxDAQhoOsuB_6FyRHL4WkaZLGm-yXyoIe1nNJ08la2aY1aZX-eyPugnOZYebh5WHmaOJaBxdoRqWiieSMTP7NUzQP4YMQIVTOrtA05URykrMZ0ivowfR163Brcf8--rausNHOgMfliLXDm9U2eV3vz8tgPICr3QF3vj143dxjjZ91px0EwE7_ZiXfdQU4DP4Lxmt0afUxwM2pL9DbZr1fPia7l-3T8mGXdCmlfcIti7o8F1KSUmQZWJuRCkwlgOQyoyxWqYxSlJQUlAQL1pQ8HkQaQcIW6O4vN2p9DhD6oqmDgeMxirVDKCjnhEihOI_o7QkdygaqovN1o_1YnN_CfgDUqGAf |
ContentType | Journal Article |
Copyright | Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Copyright_xml | – notice: Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1791-7530 |
ExternalDocumentID | 25075083 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 23M 53G 5GY 5RE 5VS ADBBV AENEX AFFNX AIZAD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CGR CUY CVF DIK EBS ECM EIF EJD F5P H13 KQ8 L7B NPM OK1 P2P RHI SJN UDS VRB W8F X7M ZGI ZXP 7X8 |
ID | FETCH-LOGICAL-p211t-5f3179586770b644eff40decd6e087413333b9c9910b1e97efefcb54136240d03 |
ISSN | 1791-7530 |
IngestDate | Fri Jul 11 11:08:55 EDT 2025 Thu Apr 03 07:09:11 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | screening Thyroid cancer Japan PET PET/CT |
Language | English |
License | Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p211t-5f3179586770b644eff40decd6e087413333b9c9910b1e97efefcb54136240d03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25075083 |
PQID | 1550076955 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_1550076955 pubmed_primary_25075083 |
PublicationCentury | 2000 |
PublicationDate | 2014-Aug 20140801 |
PublicationDateYYYYMMDD | 2014-08-01 |
PublicationDate_xml | – month: 08 year: 2014 text: 2014-Aug |
PublicationDecade | 2010 |
PublicationPlace | Greece |
PublicationPlace_xml | – name: Greece |
PublicationTitle | Anticancer research |
PublicationTitleAlternate | Anticancer Res |
PublicationYear | 2014 |
SSID | ssj0066983 |
Score | 2.0979908 |
Snippet | The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 4439 |
SubjectTerms | Adult Early Detection of Cancer Female Fluorodeoxyglucose F18 Humans Japan Male Middle Aged Neoplasm Staging Positron-Emission Tomography - methods Radiopharmaceuticals Thyroid Neoplasms - diagnostic imaging Thyroid Neoplasms - pathology Tomography, X-Ray Computed |
Title | Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25075083 https://www.proquest.com/docview/1550076955 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1791-7530 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066983 issn: 1791-7530 databaseCode: KQ8 dateStart: 20040101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1791-7530 dateEnd: 20231002 omitProxy: true ssIdentifier: ssj0066983 issn: 1791-7530 databaseCode: DIK dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBZNHkpfSu-mFyqUvgQVbyL5yFtodptus2kpXtg3Y0mjYAr2duNtSH59RtaRBFJIuw9mGeEDffbom9EchHzANSnnPNHM7CjJuNCC1bk2zGhuCoW6kg-5MLPj9HDOpwuxuGp3NGSX9PKTurg1r-R_UEUZ4mqzZP8B2XhRFOB_xBePiDAe74TxAfSgAuXDGV91jbZhXApWllbipzs5-MJ-jMsgRB2BdqtLQB_islyu8xRXTNuJctu5BtlZo2H7dL36c3PTd7-1ju_hQr5GUPQlzxrb2B5hHzyvP8-7ky76bgCt_hCh30TxtGnbznZiGfyvYF1h0Ytgi4H6kbL-VYch75wY8RgaF_RpVowYWkRu6wVukXkl7D2a7mXLr2lUzl2xo5ulso-_V5P50VFVjhflx-VvZruI2d1231Jlg2ygHrMU-eu3sC6naTEUZY23_7tNMXCL8hF56I0Cuu8QfkzuQfuE3J_5sIenpI5A085QDzR1UFB5TuuWeqCDMAJNPdB7tKYBZnoNZupgfkbmk3H5-ZD53hhsiSZ7z4RB4lcIW40wkchpwRj84kDpFJIcWeIu_mShkP0ncgRFBgaMkgIHUuRwOtl9TjbbroWXhILkCnnjzkgjeU6MkIbbKpAilwWozCRb5H2Ypwp1j91Qwoft1qeVNW-TLC2E2CIv3ARWS1ckpUJqndlWA6_ucPZr8uDq5XlDNvvVGt4i1-vluwHCS7jjXBs |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+thyroid+cancer+by+an+FDG-PET+cancer+screening+program%3A+a+Japanese+nation-wide+survey&rft.jtitle=Anticancer+research&rft.au=Minamimoto%2C+Ryogo&rft.au=Senda%2C+Michio&rft.au=Jinnouchi%2C+Seishi&rft.au=Terauchi%2C+Takashi&rft.date=2014-08-01&rft.issn=1791-7530&rft.eissn=1791-7530&rft.volume=34&rft.issue=8&rft.spage=4439&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1791-7530&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1791-7530&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1791-7530&client=summon |